Rare diseases
Investigational molecules
Locations
Back to Slovakia80 clinical trials in Nitra, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)SlovakiaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
SlovakiaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
SlovakiaStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
SlovakiaStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
SlovakiaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
SlovakiaStudy of Elafibranor for Adults with Primary Biliary Cholangitis
SlovakiaEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
SlovakiaEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
SlovakiaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
SlovakiaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
SlovakiaA study to evaluate the efficacy and safety of etrasimod arginine in children with moderately to severely active ulcerative colitis
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on inflammatory bowel diseases, including studies of novel therapies for both Crohn's Disease and Ulcerative Colitis. Research evaluates treatments like obefazimod and risankizumab for managing moderate to severe cases.
Comprehensive research into cardiovascular diseases, examining new treatments for heart attacks, stroke prevention, and atherosclerosis. Studies include evaluation of medications like asundexian and inclisiran for various cardiac conditions.
Advanced trials in multiple sclerosis treatment, testing innovative therapies like frexalimab and remibrutinib. Research focuses on reducing relapse rates and improving long-term patient outcomes.
Studies examining treatments for chronic kidney disease and related conditions, including research on combination therapies with dapagliflozin and investigations into hypertriglyceridemia management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
